The possibility that a bronchial inflammatory process could be involved with a chronic nonproductive cough without other potential causes such as postnasal drip syndrome, bronchial asthma, gastroesophageal reflux, chronic bronchitis, bronchiectasis, or the use of angiotensinconverting enzyme inhibitors has not been clearly described. We investigated the possibility that a chronic nonproductive cough without other potential causes is associated with airway inflammation, and if this is so, what the relationship might be between this inflammation and the possible etiology of the cough. Subjects: Twenty-five adults with chronic nonproductive cough as an isolated symptom over a 3-week period, and 5 healthy control subjects were studied. Measurements and results: Clinical assessments, cough scores, methacholine challenges, allergy skin prick tests, and bronchoscopies for bronchial biopsies were performed. In the bronchial biopsies, the patients were divided into the following two subgroups: 21 patients who were infiltrated with eosinophils vs the healthy control group ( 
C
hronic cough is defined as a cough persisting for at least 3 weeks. 1 Its pathophysiology is still poorly understood. Systemic evaluation of the potential causes of chronic cough based on the locations of afferent limbs of the cough reflex has shown that postnasal drip syndrome, gastroesophageal reflux, and asthma are the main etiologies of persistent cough. The so-called "cough-variant asthma" is also a well-known cause of cough, 2 and nonasthmatic eosinophilic bronchitis, a less common etiology, also has been described. 3, 4 Asthma is associated with airway inflammation. Boulet and colleagues 5 reported that the chronic cough observed in nonasthmatic subjects, which was caused by postnasal drip syndrome and gastroesophageal reflux, is also associated with airway inflammation. However, the possibility that a bronchial inflammatory process may be involved in a chronic nonproductive cough without the other potential causes of postnasal drip syndrome, bronchial asthma, gastroesophageal reflux, chronic bronchitis, bronchiectasis, or the use of angiotensin-converting enzyme inhibitors has not been clearly described.
We investigated the possibility that a chronic nonproductive cough without other potential causes is associated with airway inflammation, and if this is so, what the relationship might be between this inflammation and the possible etiology of the cough.
Materials and Methods

Patients
Twenty-five patients, 10 men and 15 women who were 20 to 64 years of age (mean, 39.8 year), who were referred to the Korea University Hospital for persistent dry cough of more than 3 weeks' duration were studied. The inclusion criteria included a normal pulmonary function test result, a normal chest examination and radiograph, and nonsmoking status. Exclusion criteria included postnasal drip syndrome, gastroesophageal reflux, the use of a medication known to induce chronic cough (eg, angiotensin-converting inhibitor or ␤-blockers), evidence of a respiratory tract infection in the previous 8 weeks, or a history of asthma, chronic bronchitis, or any other chest or systemic diseases. Postnasal drip syndrome was considered as an etiology if the patients experienced the sensation of "having something drip down into their throat" and/or had to clear their throat frequently, or if a physical examination of the pharynx revealed secretions or a cobblestone mucosa, with or without signs of chronic sinusitis on the sinus radiograph, as suggested by a thickening of the sinus mucosa.
Gastroesophageal reflux was considered if the 24-h measurement of the esophageal pH was positive. Coughers were compared with a group of healthy control subjects (three men and two women; mean age, 57.2 years). The control subjects were nonsmokers and had normal chest radiograph results, normal airway reactivity, and normal results of pulmonary function testing. They had no current respiratory symptoms, were nonatopic, and had had no respiratory tract infection within the previous month. No control subjects were receiving any medications. The study protocol was approved by the ethics committee of Korea University College of Medicine, and written informed consent was obtained from all patients and control subjects.
Procedures
All patients and control subjects were given a thorough evaluation, which included the subjective measurement of cough severity, methacholine challenge, allergy skin prick tests, and fiberoptic bronchoscopy for bronchial biopsies, in order to evaluate airway inflammation. The severity of the cough was rated using the cough score (Table 1) . 6 The methacholine challenge was performed using the following method. Acetyl methacholine chloride (Sigma; St. Louis, MO) was diluted with normal saline solution and was divided into nine concentrated solutions ranging from 0.075 to 25 mg/mL. Each concentrated methacholine solution was inhaled five times through a nebulizer (DeVilbiss Pulmo-aide Compressor/Nebulizer; SM Instruments; Doylestown, PA) and a dosimeter (MicroDosimeter; Sunrise Medical; Carlsbad, CA). FEV 1 was measured after each inhalation, and the provocative concentration of methacholine resulting in a 20% fall in FEV 1 from the baseline measurement (PC 20 ) was subsequently calculated from a logresponse curve using linear interpolation. A positive airway hyperresponsiveness was defined when the PC 20 was Ͻ 8 mg/ mL.
Allergy skin prick tests were performed with a solution (Bencard; Brentford, UK) of 55 common allergen extracts. The sizes of the wheal and the area of erythema were measured with a skin test reaction gauge (Bencard) 15 min after the skin prick. A negative result on the test indicated that there was no reaction induced by an allergen but that there was a normal reaction to the controlled histamine solution. A score of 1ϩ was given to areas of erythema of Ͻ 21 mm, and a score of 2ϩ was given for areas of erythema of Ͼ 21 mm, with the ratio of the wheal size of Ͻ 1 compared to that induced by the histamine-controlled solution. The ratios between 1 and 2 were given a score of 3ϩ. Ratios between 2 and 3 were given a 4ϩ. Scores of Ͼ 2ϩ were designated as atopic.
A bronchoscopic biopsy was performed under local anesthesia with 2% lidocaine spray using flexible bronchoscopy (model BF 1T30; Olympus; Tokyo, Japan). The oxygen saturation and pulse rate were checked by pulse oximetry during the procedure. From the carina of the second and third segment of the right bronchus, three or four pieces of tissue were obtained, were fixed with 10% formalin, were embedded on paraffin, were sliced at a 6-m thickness, were stained with hematoxylin-eosin, and were examined under a light microscope.
Assessment of Airway Inflammation
Inflammatory cell counts and basement membrane thickness were measured from the histologic sections. To avoid observer bias, all microscopic slides were coded prior to analysis by one pathologist and were analyzed blindly, in terms of the patients' clinical data. Inflammatory cell counts were calculated manually from the light microscopy using a graticule (eyepiece micrometer; Olympus) at ϫ200 magnification. The cell counts were measured as the mean number of cells per square millimeter (ie, 1 mm 2 ) measured at three different sections. Differential counts of lymphocytes, basophils, eosinophils, plasma cells, and so forth were performed. Only the surface of the connective tissue was considered, excluding both smooth muscle cells and mucus glands. Cell differentiation was based on the type of nuclei and granules inside the cells. The cells were counted only if the nuclei were observed. The thickness of the basement membrane was assessed on three sections stained with hematoxylin-eosin and was measured from the base of the bronchial epithelium to the outer limit of the reticular lamina of the basement membrane using a micrometer at ϫ400 magnification. The final result was the mean of all measurements obtained for each biopsy specimen.
Statistical Analysis
All statistical analyses were performed using statistical software (SAS, version 6.12; SAS Institute; Cary, NC). The results were expressed as the mean values of FEV 1 , FVC, peak expiratory flow (PEF), and the thickness of the basement membranes, and as the median and range for cell counts from biopsy specimens. The Wilcoxon two-sample test was used to compare the mean values 
Results
Patient Characteristics
The patient pool consisted of 10 men and 15 women, ranging in age from 20 to 64 years ( Table 2 ). The mean (Ϯ SD) baseline daily cough scores were 3.68 Ϯ 0.75. The duration of the cough symptoms of the patients ranged from 3 weeks to Ͼ 10 years, with 2 to 6 months being considered the most prevalent duration (10 patients; 40%) ( 
Assessment of Airway Inflammation
The patients were divided into an eosinophilinfiltrated group and a lymphocyte-infiltrated group (Fig 1, 2) . The eosinophil-infiltrated group was considered to have Ͼ 3% occupancy of all cells, 4 irrespective of other inflammatory cell counts. The lymphocyte-infiltrated group was considered to have more than twice the number of lymphocytes of the control group (Fig 3) or to have Ͼ 60% occupancy without increasing the numbers of other inflammatory cells. The eosinophil-infiltrated group consisted of 21 patients with a median eosinophil count of 12.0 cells/mm 2 , while the median eosinophil count of the 
Etiologic Diagnosis
The causes of chronic nonproductive cough in the patients were inferred from the methacholine challenge results and the pathologic findings. Five of 21 patients of the eosinophil-infiltrated group could receive diagnoses of cough-variant asthma due to positive results to the methacholine challenge. However, 16 patients with negative results to the methacholine challenge could receive diagnoses of eosinophilic bronchitis. All four patients in the lymphocyte-infiltrated group were shown to have negative results for the methacholine challenge and manifested lymphocytic bronchitis (Fig 4) . Three of 16 eosinophilic bronchitis patients and 2 of 5 cough-variant asthma patients had atopy. The lymphocytic bronchitis patients did not have atopy.
Discussion
Two studies 4, 5 indicate that chronic cough is associated with airway inflammation. It is not clear how the airway inflammation affects the cough reflex and airway responsiveness, yet the hypothesis that epithelial cell damage could lead to an increased cough reflex is highly supported. 5 Denudation of the sensory nerve endings by epithelial damage due to the inflammation may result in an increased cough reflex to exogenous or endogenous factors. Epithelial damage along with inflammatory cell infiltration have been observed in patients with chronic cough. This is supported by studies [7] [8] [9] showing that steroids assist in healing the damaged epithelial cells by suppressing the infiltration of inflammatory cells, and that they also participate in regenerating the destroyed cilia, which results in a reduction of coughing. Therefore, the pathogenesis of chronic cough can be summarized as the damage of epithelial cells due to airway inflammation.
In this study, an increase in inflammatory cell infiltration and a thickening of the basement membrane in the patient group were found, in contrast with the control group. Mostly, the inflammatory cells were either eosinophils or lymphocytes. Typically, no significant differences were observed between the patient and control groups in the number of inflammatory cells, with the exceptions of the number of eosinophils and lymphocytes. Therefore, we evaluated the patient group according to the number of eosinophils and lymphocytes. First, we defined the patients with increased eosinophils, as compared with the number of eosinophils in the healthy control group, to be an eosinophil-infiltrated group. Then, we defined the patients with increased lymphocytes, as compared with the number of lymphocytes in the healthy control group, to be a lymphocyte-infiltrated group. On the basis of inflammatory cell infiltration of the bronchial mucosa and the results of the methacholine challenge, we were able to consider the causes of chronic nonproductive cough in the patients as cough-variant asthma, eosinophilic bronchitis, or bronchitis with lymphocyte infiltration. For the investigation of bronchitis with lymphocyte infiltration in this study, we think that a term such as lymphocytic bronchitis perhaps would be a useful label during further investigation of this type of airway inflammation. Our data suggest that the assessment of airway inflammation is an important addition for the investigation of chronic nonproductive cough. 4 We chose to assess airway inflammation with bronchoscopic biopsies instead of sputum induction, since it is difficult to obtain successful results with the sputum induction method in patients with dry cough. Although bronchoscopic biopsies are invasive, we believe that this method is more precise for the assessment of airway inflammation.
Cough-variant asthma was first named by Glauser 10 in 1972 and is defined as a condition of nonsmoking patients who have coughed for at least 3 weeks without other symptoms but who have normal results of physical examinations, normal or almost normal spirometry values, and positive results of bronchial provocation testing. 2,10 -13 It was reported that cough-variant asthma could reach up to 29% of all patients with chronic cough and up to 7 to 11% of all asthma patients. 13, 14 However, many cases were overlooked without being diagnosed. Therefore, patients with a nonspecific chronic cough, such as a nocturnal dry cough or aggravated cough after exercise and exposure to cold air, and with an atopic allergy history, either family or individual, must be suspected. 2, 11, 13, 14 In this study, 40% (two of five patients) of cough-variant asthma patients showed atopy, which was not significantly different from the 25 to 35% seen in cases of classic asthma.
Eosinophilic bronchitis was suggested by Gibson et al 3 in 1989 and was defined as an eosinophilic airway inflammation with chronic cough as an isolated symptom with normal spirometry values and normal methacholine airway responsiveness. It is a new disease that does not have the diurnal variability of PEF or airway responsiveness to histamine, adenosine 5Ј-monophosphate, and methacholine. No specific association between airway inflammation and airway hyperresponsiveness was inferred in cases of eosinophilic bronchitis. 15 Its pathogenesis is not yet clear. However, it was suggested that airway inflammation by eosinophils and mast cells might be associated with the cough and heightened airway responsiveness but were not sufficient for the development of the wheeze, airway hyperresponsiveness, or airway obstruction that is characteristic of asthma. 15 We measured eosinophilic airway inflammation in patients with eosinophilic bronchitis and coughvariant asthma. There tend to be more eosinophils in patients with cough-variant asthma than in those with eosinophilic bronchitis. However, due to the small number of patients in the study, any statistically significant conclusions could not be made. Further investigations on the relationship between the eosinophilic bronchitis and cough-variant asthma are needed.
To our knowledge, there have not been any large studies performed regarding the association with atopy, and nothing has yet been proven. This study demonstrated the relevance of atopy to be 18.8% (ie, 3 of 16 patients).
Compared with previous studies, the results of this study suggested that eosinophilic bronchitis may be the causative disease of a chronic nonproductive cough 15 and for the first time provided histopathologic evidence to that end. Furthermore, in this study, 16 patients demonstrated signs of eosinophilic bronchitis, which is three times the rate in coughvariant asthma patients (5 patients). These results indicate that there are more cases of undiagnosed eosinophilic bronchitis because cough-variant asthma has been linked to chronic cough in only 29% of the reported cases. Therefore, more interest and effort are crucial in diagnosing unrecognized eosinophilic bronchitis.
Patients with lymphocytic bronchitis were identified by their morphologic features. The patients with this disease may have other specific diseases that the authors could not diagnose, or it may truly be a whole new disease. However, there was no evidence of other possible diseases to account for the finding. Also, Boulet and colleagues 5 reported an increase in lymphocytic infiltration in the bronchial tissues of patients with chronic nonproductive cough without any definitive causes. This issue should be investigated in future studies. Until then, we think that a term such as lymphocytic bronchitis would be a useful label.
The specific cause of lymphocytic bronchitis was not identified but was considered to be a nonspecific inflammatory reaction. In the lungs, lymphocytes, along with macrophages, play an important role in the inflammatory and immune reactions. The macrophage, as a phagocytic cell, is not antigen-specific. The lymphocyte represents a significant refinement in the inflammatory response (ie, antigen specificity and discrimination of the self and other). In other words, lymphocytes produce a defense mechanism against the invasion of antigens and microorganisms by antibody production, cytotoxic activity, or cytokine production. 16, 17 These lymphocytes are activated in particular when foreign antigens overwhelm mucociliary escalators, macrophages, and neutrophil defenses. 18 The patients with lymphocytic bronchitis did not have any specific history of exposure or any occupational history. But since the lung is stimulated by a large number of foreign infectious and noninfectious antigens on the tide of airflow, it would be very difficult to actually find specific causative antigens.
The clinical features of lymphocytic bronchitis such as severity of cough and duration of symptoms did not differ from those of eosinophilic bronchitis. However, the lymphocytic bronchitis patients did not have atopy. Oral prednisolone, 30 mg once a day for 2 weeks, was prescribed to each patient with lymphocytic bronchitis. The cough score was measured before and after the treatment. Three of four patients had improved symptoms (change in cough scores: 3 to 0; 4 to 1; and 3 to 1), but one patient had no improvement (change in cough score, 4 to 3). The effects of steroid therapy need further study such as with a placebo-controlled study.
As mentioned above, chronic cough is the result of epithelial damage due to inflammatory cell infiltration. However, the role of lymphocytes in epithelial damage is controversial 19 and requires further investigation.
Conclusion
Chronic nonproductive cough as an isolated symptom without other potential causes, such as postnasal drip syndrome, bronchial asthma, gastroesophageal reflux, chronic bronchitis, bronchiectasis, or the use of angiotensin-converting enzyme inhibitors, is associated with airway inflammation by the infiltration of inflammatory cells that are composed mainly of eosinophils and lymphocytes. The causes are eosinophilic bronchitis, cough-variant asthma, and lymphocytic bronchitis (in order of frequency). Airway inflammation has a useful role in the assessment of chronic nonproductive cough.
